MYD88 and colitis: In mouse models with dextran sulphate sodium (DSS) induced colitis, d‐Ala supplementation suppressed the growth of harmful bacteria (E. coli and K. pneumoniae) alleviating colitis primarily by modulating Toll‐like receptors–MyD88 signaling [97].